Cancer BiologybioRxivPreprint
A novel imaging biomarker for survival prediction in EGFR-mutated NSCLC patients treated with TKI
A. Collin, V. Groza, L. Missenard…·O. Saut
This study develops an imaging biomarker based on tumor heterogeneity evolution to predict survival in EGFR-mutated NSCLC patients treated with TKI, showing a statistically significant correlation with overall survival.